Journal article

Maintenance therapy in CLL: resolving the controversy

Constantine S Tam

The Lancet Haematology | ELSEVIER SCI LTD | Published : 2016

DOI: 10.1016/S2352-3026(16)30046-1

Keywords

Phase-3
Chronic Lymphocytic-Leukemia
Life Sciences & Biomedicine
Open-Label
Rituximab
Antineoplastic Agents
Humans
Science & Technology
Fludarabine
Trial
Leukemia, Lymphocytic, Chronic, B-Cell
Multicenter
Cyclophosphamide
Hematology